Skip to content. | Skip to navigation
Personal tools
- Contact Us |
- Seminars |
- Donate
Lunenfeld-Tanenbaum
Research Institute
Mount Sinai Hospital
Joseph & Wolf Lebovic Health Complex
600 University Avenue
Toronto Ontario
M5G 1X5
Tel.: 416-586-4800 ext.8747
► The Prosserman Centre for Population Health Research
► Web of Science Researcher ID
E-7266-2013
Dr. Bernard Zinman
SENIOR INVESTIGATOR
Dr. Bernard Zinman, a clinician-scientist at Mount Sinai, is a recognized leader in the field of diabetes. His research focuses on the prevention of the long-term complications of diabetes, new treatments for diabetes, and diabetes in high-risk populations. His research holds promise for increased understanding of how to deal with this growing, global epidemic.
For more than 25 years, Dr. Zinman has played a key role in the Diabetes Control and Complications Trial, the largest and most comprehensive diabetes complications study ever conducted in Type 1 diabetes. This pivotal study demonstrated that keeping blood glucose levels as close to normal as possible slows the onset and progression of eye, kidney, and nerve complications caused by diabetes. One of the most cited diabetes study in the world, this study had a global impact on treatment of Type 1 diabetes patients and the occurrence of complications.
Dr. Zinman was inaugural Director of the Leadership Sinai Centre for Diabetes, a unique, multi-disciplinary outpatient unit that is one of the largest diabetes clinical research units in Ontario. The Centre provides the highest quality care by integrating clinical practice, research and education for those with diabetes and their families.
At a Glance
Dr. Bernard Zinman is a clinician-scientist whose research interests include both type 1 and type 2 diabetes
His team focuses on the long-term complications of diabetes, evaluating new therapies, and diabetes in Aboriginal communities
Major Research Activities
Dr. Zinman's research interests include both type 1 and type 2 diabetes. His research team focuses on three areas: the long-term complications of diabetes, evaluation of new therapies, understanding the underlying causes of type 2 diabetes in Aboriginal communities. Since 1992, Dr. Zinman and his collaborators have been examining the prevalence of diabetes and its associated risk factors in Sandy Lake, an isolated native community located in the Sioux Lookout Zone of northwestern Ontario.
